279 related articles for article (PubMed ID: 26919280)
1. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
Zhang S; Liu Q; Xiao J; Lei J; Liu Y; Xu H; Hong Z
Int Immunopharmacol; 2016 May; 34():32-36. PubMed ID: 26919280
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Smad2/3 and specific isoforms of ERK in TGF-β1-induced TIMP-3 expression in rat chondrocytes.
Zhu Y; Gu J; Zhu T; Jin C; Hu X; Wang X
J Cell Mol Med; 2017 Sep; 21(9):1781-1790. PubMed ID: 28230313
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
5. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
6. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of transforming growth factor-beta1, connective tissue growth factor, phosphorylated-SMAD2/3 and phosphorylated-ERK1/2 during mouse tooth development.
Li S; Pan Y
J Mol Histol; 2017 Dec; 48(5-6):347-355. PubMed ID: 28825193
[TBL] [Abstract][Full Text] [Related]
8. [Effect of enalapril on the expression of TGF-beta1, p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats].
Ning W; Tao L; Liu C; Sun J; Xiao Y; Hu J; Chen J; Zheng X; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):27-34. PubMed ID: 19197123
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
[TBL] [Abstract][Full Text] [Related]
10. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats].
Bao JF; Shi JP; Xu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):334-7. PubMed ID: 22338217
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
14. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells.
Kolosova I; Nethery D; Kern JA
J Cell Physiol; 2011 May; 226(5):1248-54. PubMed ID: 20945383
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways.
Weng CH; Li YJ; Wu HH; Liu SH; Hsu HH; Chen YC; Yang CW; Chu PH; Tian YC
Biomed Pharmacother; 2020 Mar; 123():109741. PubMed ID: 31901549
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
18. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
19. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
20. Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts.
Nakagawa T; Lan HY; Glushakova O; Zhu HJ; Kang DH; Schreiner GF; Böttinger EP; Johnson RJ; Sautin YY
J Am Soc Nephrol; 2005 Apr; 16(4):899-904. PubMed ID: 15716330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
